rs139337049

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_012414.4(RAB3GAP2):​c.2290C>T​(p.Leu764Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00157 in 1,613,938 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00097 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 3 hom. )

Consequence

RAB3GAP2
NM_012414.4 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:6B:3

Conservation

PhyloP100: 2.46
Variant links:
Genes affected
RAB3GAP2 (HGNC:17168): (RAB3 GTPase activating non-catalytic protein subunit 2) The protein encoded by this gene belongs to the RAB3 protein family, members of which are involved in regulated exocytosis of neurotransmitters and hormones. This protein forms the Rab3 GTPase-activating complex with RAB3GAP1, where it constitutes the regulatory subunit, whereas the latter functions as the catalytic subunit. This gene has the highest level of expression in the brain, consistent with it having a key role in neurodevelopment. Mutations in this gene are associated with Martsolf syndrome.[provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010350466).
BP6
Variant 1-220182277-G-A is Benign according to our data. Variant chr1-220182277-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 235683.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=5}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000973 (148/152176) while in subpopulation NFE AF= 0.00154 (105/68004). AF 95% confidence interval is 0.0013. There are 0 homozygotes in gnomad4. There are 61 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RAB3GAP2NM_012414.4 linkuse as main transcriptc.2290C>T p.Leu764Phe missense_variant 21/35 ENST00000358951.7 NP_036546.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RAB3GAP2ENST00000358951.7 linkuse as main transcriptc.2290C>T p.Leu764Phe missense_variant 21/351 NM_012414.4 ENSP00000351832 P2Q9H2M9-1

Frequencies

GnomAD3 genomes
AF:
0.000973
AC:
148
AN:
152058
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000786
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.0000945
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00154
Gnomad OTH
AF:
0.00143
GnomAD3 exomes
AF:
0.00103
AC:
260
AN:
251316
Hom.:
0
AF XY:
0.000994
AC XY:
135
AN XY:
135834
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.000434
Gnomad ASJ exome
AF:
0.00268
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000392
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.00167
Gnomad OTH exome
AF:
0.00179
GnomAD4 exome
AF:
0.00163
AC:
2386
AN:
1461762
Hom.:
3
Cov.:
34
AF XY:
0.00153
AC XY:
1116
AN XY:
727186
show subpopulations
Gnomad4 AFR exome
AF:
0.000149
Gnomad4 AMR exome
AF:
0.000402
Gnomad4 ASJ exome
AF:
0.00188
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000452
Gnomad4 FIN exome
AF:
0.0000936
Gnomad4 NFE exome
AF:
0.00191
Gnomad4 OTH exome
AF:
0.00230
GnomAD4 genome
AF:
0.000973
AC:
148
AN:
152176
Hom.:
0
Cov.:
32
AF XY:
0.000820
AC XY:
61
AN XY:
74406
show subpopulations
Gnomad4 AFR
AF:
0.000361
Gnomad4 AMR
AF:
0.000785
Gnomad4 ASJ
AF:
0.00288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000415
Gnomad4 FIN
AF:
0.0000945
Gnomad4 NFE
AF:
0.00154
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.00145
Hom.:
0
Bravo
AF:
0.00102
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00209
AC:
18
ExAC
AF:
0.00106
AC:
129
EpiCase
AF:
0.00174
EpiControl
AF:
0.00148

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:6Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsJan 21, 2016- -
Uncertain significance, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-The RAB3GAP2 p.Leu764Phe variant was not identified in the literature but was identified in dbSNP (ID: rs139337049) and ClinVar (classified as uncertain significance by Invitae, Illumina, Genetic Services Laboratory, University of Chicago, Fulgent Genetics and Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics). The variant was identified in control databases in 280 of 282664 chromosomes at a frequency of 0.0009906 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: Ashkenazi Jewish in 28 of 10362 chromosomes (freq: 0.002702), European (non-Finnish) in 206 of 129038 chromosomes (freq: 0.001596), Other in 11 of 7216 chromosomes (freq: 0.001524), Latino in 18 of 35436 chromosomes (freq: 0.000508), South Asian in 12 of 30614 chromosomes (freq: 0.000392), African in 4 of 24946 chromosomes (freq: 0.00016) and European (Finnish) in 1 of 25102 chromosomes (freq: 0.00004), but was not observed in the East Asian population. The p.Leu764 residue is conserved in mammals but not in more distantly related organisms however four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
Likely benign, criteria provided, single submitterclinical testingGeneDxMay 12, 2021- -
Martsolf syndrome;C3280214:Warburg micro syndrome 2 Uncertain:1Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 22, 2023- -
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 31, 2018- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoNov 18, 2015- -
Warburg micro syndrome 2 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Martsolf syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
RAB3GAP2-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesFeb 03, 2022This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Benign
0.034
T
Eigen
Benign
-0.44
Eigen_PC
Benign
-0.25
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Benign
0.84
T
M_CAP
Benign
0.0065
T
MetaRNN
Benign
0.010
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.40
N
MutationTaster
Benign
0.84
D
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.025
Sift
Benign
0.36
T
Sift4G
Benign
0.37
T
Polyphen
0.0010
B
Vest4
0.20
MVP
0.11
MPC
0.16
ClinPred
0.016
T
GERP RS
2.9
Varity_R
0.12
gMVP
0.44

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139337049; hg19: chr1-220355619; API